E-nose in Evaluating Colitis Activity
Observational · No treatment assigned · Sites not listed yet · Tampere University Hospital
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: IBD (Inflammatory Bowel Disease). This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 1 to 16
- Any sex
- Healthy volunteers accepted
Some of the main requirements, copied from the record:
- Scheduled for colonoscopy by pediatric gastroenterologist
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 120 participants are expected to take part.
- Start date: 2026-08-21 (planned).
- Main results expected around 2036-12-31 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- Images of Fecal molecular profile (FMP) in children with and without IBD (DMS analysis will be performed at each outpatient visit every 3 months during the 5 year follow-up)
In the researchers’ words
The goal of this observational study is to learn whether a rapid stool-based imaging test can help monitor inflammatory bowel disease (IBD) in children. The study will use a technology called differential mobility spectrometry (DMS) to analyze the molecular profile of stool samples.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | IBD (Inflammatory Bowel Disease) |
| Lead sponsor | Tampere University Hospital |
| Collaborators | Olfactomics Oy |
| Enrollment | 120 (estimated) |
| Start date | 2026-08-21 |
| Primary completion (est.) | 2036-12-31 |
| First posted | 2026-08-24 |
| Last updated | 2026-09-10 |
| Official title | Stool Profile in Evaluating Colitis Treatment Response, Outcome and Severity |
| ClinicalTrials.gov ID | NCT07781215 |
Interventions
- Differential Mobile Spectrometry analysis of the stool (Other)
The stool that is checked for faecal calprotectin will also be analysed using the DMS, which generates different ion spectra that will be referred as faecal molecular profile (FMP).
Full eligibility criteria (from the record)
Inclusion Criteria: * Scheduled for colonoscopy by pediatric gastroenterologist Exclusion Criteria: * None
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.